Sadly, I don't have a book to recommend. Most of the targeting today is happening through antibodies, but the majority of LNP delivery at this point is done passively without targeting mechanisms on the LNP (Needle injection point aside). That's actually one advantage of CRISPR over just injecting mRNA - you can target specific cell-lines (Even if you change the genome of many cell types) by using cell-specific promoters for the edits you make instead of relying on surface affinity based targeting of the LNP. Interesting resources: [0]: https://www.nature.com/articles/nrd.2017.243 (General review 1) [1]: https://www.frontiersin.org/articles/10.3389/fmolb.2020.5879... (General review 2) [2]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498813/ (PCSK9 target again, but via siRNA actuator) [3]: https://genomebiology.biomedcentral.com/articles/10.1186/s13... (Example of cell-specific CRISPR integration)
mRNA vaccines — a new era in vaccinology
Norbert Pardi, Michael J. Hogan, Frederick W. Porter, Drew Weissman
2018 · Nature Reviews Drug Discovery
- HN score
- 1
- Mentions
- 14
- Readers
- 14
- Months
- 9
In the conversation
Original HN comments, with labels from simple text rules. A label describes the whole comment and may miss context or irony. Read the discussion to make up your own mind. About the labels
14 selected excerpts · 14 total mentions
Nature.com doesn't agree with you. At least in 2019 it wasn't controversial to say so: "Because mRNA falls into the broad vaccine category of genetic immunogens, many of the guiding principles that have been defined for DNA vaccines (162) and gene therapy vectors (163,164) can likely be applied to mRNA with some adaptations to reflect the unique features of mRNA." [0] And still in 2021, Nature.com felt they were gene therapies: "However, these mRNA vaccines, which have been developed and approved within a few months, signify a breakthrough in the field of gene therapy, which has battled to achieve ordinary acknowledgement due to a large number of sceptical and conservative scientists and other claimed safety and translational concerns."[1] [0] https://www.nature.com/articles/nrd.2017.243 [1] https://www.nature.com/articles/s41435-021-00136-6
Forgive me for pattern-matching your political leanings; it's insufferable to deal with a dozen variants of "it's just a flu" mutated from the dear leader's mouth over here. You're right, real dialog on scientific matters is getting impossible, because people can't do basic research. If you'd like to read up on mRNA vaccines, here's an article from the pre-COVID days, before something as simple as a scientific advancement to fight disease became so politically charged. https://www.nature.com/articles/nrd.2017.243 Ecological activists, by numbers, are a round off error in the debate over this vaccine. It is absolutely tainted with politics, as the majority of anti-vaxxers…
Read the full comment
land on one side of the political spectrum. I know some. It's everything from "it's the mark of the beast" to "I'm not so sure about this". What really underlies it is a deep, irrational selfishness that doesn't want to do a damn thing, even if, and especially if COVID doesn't seem that risky for that person. That whole line of reasoning is a fail. People who want the pandemic to be over know that vaccination is the only way. Sitting on your ass, no matter what is in your head, and being another vessel for this shit to mutate is actively prolonging it. So yeah, I absolutely pounce on ignorant people who are prolonging this.
> mRNA is a new, unknown technology This is untrue, researchers have been testing various mRNA therapies on people for 30 years, with it being first done in vitro in 1990 then in vivo in 1992 [1]. Lipid nano particles were first used around the same time. > the vaccine was rushed faster to public access than any other vaccine before This is only true if you ignore the development of the mRNA vaccine platform for flu, rabies, and zika that predated the pandemic by years. The novel development here was swapping in new protein encoding. If you look at this as a continuation of that process, then it's only a little faster than normal, and a lot of that was due to the FDA…
Read the full comment
switching sequential steps in the process to be parallel. > We have absolutely no idea if there are any long term side effects of these vaccines. This isn't a meaningful claim for 2 key reasons. There has never been a vaccine that had serious side effects that did show up shortly after vaccination[2]. The history of mRNA treatments began as an experiment in gene therapy, but has largely ben abandoned because the effects never lasted long enough. As of 2020 this is an ongoing area of research[3]. No one has figure out how to stabilize mRNA so that it has long lasting effects. > Both candidates Biden and Harris They're both craven, ignorant politicians, who cares what they said when the other guy was in power. [1] https://www.nature.com/articles/nrd.2017.243 [2] https://www.cdc.gov/vaccinesafety/concerns/concerns-history.... [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076378/ [edit] All that said, I am no pro mandate but seriously you should all voluntarily go get vaccinated IMHO.
As I said elsewhere, I don't know the numbers, but it's non-zero. Here's a link to a 2018 article in Nature - https://www.nature.com/articles/nrd.2017.243 Particularly this table calls out some of the trials that were completed or ongoing at the time - https://www.nature.com/articles/nrd.2017.243/tables/2 I imagine the cancer vaccine trial wasn't successful, as the current mRNA vaccines are indeed the first to enter public use.
The sequence can be changed and optimized for several reasons: * There are untranslated regions (UTR) that could influence the regulation or stability of the mRNA. * Since most amino acids are encoded by more than codon, the coding region for the spike protein can be codon optimized. Altering the codon composition can improve protein expression. * Likewise, enrichment of G:C content in the mRNA sequence might result in increased mRNA and expressed protein yields in vivo. See https://www.nature.com/articles/nrd.2017.243#Sec4 for more information. Edit: > Do both of these sequences express the same protein? In this case both vaccines express exactly the same amino acid…
Read the full comment
sequence. > Or is there a "close enough!" thing in the immune system, where it can be a little different and still be targeted by the immune system? It depends on how different the sequence is. For instance, if it is a little different the immune response should be very similar because, for example, the three-dimensional conformation of the spike protein chain should remain very similar as well. This is why the vaccines can be effective against several SARS-CoV2 variants.
I don't know how my reasoning could be more "based", but here--- listen to some pharmaceutical and vaccine experts and see what you think. Here's what Derek Lowe had to say: https://blogs.sciencemag.org/pipeline/archives/2021/01/21/mr... So to get a good RNA vaccine, you frankly have to make it work like a particularly stealthy virus, and not trip every single alarm before your payload gets a chance to enter the cells. But as mentioned, some activation of the innate system is needed to get the adjuvant boost. A lot of that work has to be done empirically, which is why we’ve seen so many RNA and DNA formulation ideas over the years. None of these have been stupid ideas…
Read the full comment
(far from it) but some of them work better than others, and the current lipid nanoparticle ones are the current state of the art – the LNPs themselves activate the innate immune system, but in a way that doesn’t seem to trigger too much of a self-defeating cytokine response. It’s a useful enough effect that they’re being proposed as adjuvant additions to other, more traditional vaccines for that effect alone. Me: Both the LNPs and the mRNA itself stimulate the immune system. Basically the vast majority of work in mRNA drugs for the last decade has been to try to reduce that-- and associated toxicity and unpredictable clearance. Meanwhile, the (right amount of) immunogenicity has been accepted as a feature in vaccine candidates. And in a series of journal articles e.g. in Frontiers in Immunology: https://www.frontiersin.org/articles/10.3389/fimmu.2018.0222... "This was observed in the case of administration of empty PEGylated liposomes, which were able to elicit IgM response in an in-vivo model. (27, 28). Besides their potential to deliver various immune stimulators to the specific sites as well as into the deep tissues where vaccine molecules alone may not able to reach, these NPs have also been exploited as adjuvants to augment immunogenicity of vaccine candidates." Nature / npj Vaccines: https://www.nature.com/articles/s41541-020-0159-8 "Thus, multi-antigen candidates necessitate a significant amount of LNP for a given dose. LNPs are known to have inherent adjuvant properties." Nature / npj vaccines: https://www.nature.com/articles/nrd.2017.243 "Exogenous mRNA is inherently immunostimulatory, as it is recognized by a variety of cell surface, endosomal and cytosolic innate immune receptors (Fig. 1) (reviewed in Ref. 35). Depending on the therapeutic application, this feature of mRNA could be beneficial or detrimental. It is potentially advantageous for vaccination because in some cases it may provide adjuvant activity to drive dendritic cell (DC) maturation and thus elicit robust T and B cell immune responses. ... The immunostimulatory properties of mRNA can conversely be increased by the inclusion of an adjuvant to increase the potency of some mRNA vaccine formats. These include traditional adjuvants as well as novel approaches that take advantage of the intrinsic immunogenicity of mRNA"
To prevent an immune response and degradation, the mRNA vaccine nucleosides are modified from normal human mRNA. It's possible that RNA virus reverse transcriptase may not be able to work on these modified nucleosides. https://www.nature.com/articles/nrd.2017.243
This paper from two years ago answers a lot more questions about how mRNA vaccines work, how long the mRNA stays active, how to prevent runaway infection, etc. https://www.nature.com/articles/nrd.2017.243
This is a good summary paper with some safety concerns: https://www.nature.com/articles/nrd.2017.243.pdf?origin=ppub > A possible concern could be that some mRNA-based vaccine platforms 54,166 induce potent type I interferon responses, which have been associated not only with inflammation but also potentially with autoimmunity 167,168 . Thus, identification of individuals at an increased risk of autoimmune reactions before mRNA vaccination may allow reasonable precautions to be taken. Another potential safety issue could derive from the presence of extracellular RNA during mRNA vaccination. Extracellular naked RNA has been shown to increase the permeability of tightly…
Read the full comment
packed endothelial cells and may thus contribute to oedema 169. Another study showed that extracellular RNA promoted blood coagulation and pathological thrombus formation 170. Safety will therefore need continued evaluation as different mRNA modalities and delivery systems are utilized for the first time in humans and are tested in larger patient populations.
I don't know much about this subject but i found https://www.nature.com/articles/nrd.2017.243 to be quite interesting. Its from 2018, before all the covid stuff hit, so i think it gives a much more detached overview. However it might not be precisely about the current crop of vaccines.
Nature published a relatively easy-to-consume article about mRNA vaccine technology in 2018, which is perhaps good reading as we try to interpret the meaning of these recent announcements: https://www.nature.com/articles/nrd.2017.243
>"Fascinating--do you have any links to further reading/watching about this?" https://www.nature.com/articles/nrd.2017.243 The basic idea is that now rather than needing to culture live viruses in chicken eggs, we can literally just encode the RNA for a specific antigen into a synthetic substrate and produce vaccines through a chemical process like any other drug. The RNA is then absorbed into your cells, and your own body creates the proteins which stimulate an immune response.
Thanks for the reply, it made me think about the book idea. The topic is still too new for a book, but it's a good idea; maybe more of a treatise needs to be written on the subject right now. Regardless, the parents of modern mRNA vaccinology are Katalin Karikó and Drew Weissman. If you want to go down the rabbit hole, follow his publications. Here are a couple good reviews to get you started (https://www.nature.com/articles/nrd.2017.243 and https://www.nature.com/articles/nbt.3812). I say modern, because the idea of using modified chemistry is likely going to be key to a successful mRNA vaccine. Without it, the immunogenicty leads to safety concerns and a reduction in…
Read the full comment
transcript expression--it's just too hot. CureVac founder and arguably the first person to really drive the idea of an mRNA vaccine into the clinic is Ingmar Hoerr, but his company started before the idea of modified chemistry. He is a fantastic scientist, but ultimately CureVac came too soon and has triple-downed on canonical uridine. Another issue is they likely can't get FTO so they don't really have a choice. As for blogs/twitter accounts, none of the mRNA people are active on social media likely because the stakes are just too high right now. If you're interested in mRNA beyond vaccines, check out Sek Kathiresan on twitter. He's active. He's the CEO of Verve. Worst kept secret of the gene editing (e.g., CRISPR) world is that everyone is pivoting to using mRNA for expression of the editing enzymes (e.g., CAS9, ADAR, APOBECs).
Keep following the thread.
More in Biology & medicineMore from the same topics.
NP-complete Problems and Physical Reality
Scott Aaronson
Can NP-complete problems be solved efficiently in the physical universe?
Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma
Purna Mukherjee, Zachary M. Augur, Mingyi Li +10
AbstractGlioblastoma (GBM) is an aggressive primary human brain tumour that has resisted effective therapy for decades.
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Jackson S. Turner, Wooseob Kim, Elizaveta Kalaidina +10
The Surprising Creativity of Digital Evolution: A Collection of Anecdotes from the Evolutionary Computation and Artificial Life Research Communities
Joel Lehman, Jeff Clune, Dusan Misevic +50
Biological evolution provides a creative fount of complex and subtle adaptations, often surprising the scientists who discover them.